118 related articles for article (PubMed ID: 38493073)
1. Reply to Marco Bandini, Andrea Salonia, and Francesco Montorsi's Letter to the Editor re: Laura Elst, Manon T.A. Vreeburg, Hielke Martijn de Vries, et al. Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.005.
Elst L; Vreeburg MTA; Brouwer OR; Albersen M
Eur Urol Oncol; 2024 Mar; ():. PubMed ID: 38493073
[No Abstract] [Full Text] [Related]
2. Re: Laura Elst, Manon T.A. Vreeburg, Hielke Martijn de Vries, et al. Corporal Skip Metastases in Penile Squamous Cell Carcinoma: An Unknown and Distinct Pattern of Spread with Poor Prognosis. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.005.
Bandini M; Salonia A; Montorsi F
Eur Urol Oncol; 2024 Mar; ():. PubMed ID: 38472030
[No Abstract] [Full Text] [Related]
3. Reply to Eugenio Ventimiglia, Andrea Salonia, and Francesco Montorsi's Letter to the Editor re: Moritz von Büren, Severin Rodler, Isabell Wiesenhütter, et al. Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction. Eur Urol Focus 2022;8:794-802.
von Büren M; Wülfing C; Brookman-May SD; Gratzke C; von Büren J
Eur Urol Focus; 2023 Sep; 9(5):846-847. PubMed ID: 37061364
[No Abstract] [Full Text] [Related]
4. Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019.
Soria F; Gontero P
Eur Urol Focus; 2024 Jan; ():. PubMed ID: 38278711
[No Abstract] [Full Text] [Related]
5. Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V-Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007.
Zilli T; Ost P
Eur Urol Oncol; 2024 Feb; ():. PubMed ID: 38418267
[No Abstract] [Full Text] [Related]
6. Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010.
D'Andrea D; Soria F; Hurle R; Enikeev D; Kotov S; Régnier S; Xylinas E; Lusuardi L; Heidenreich A; Cai C; Frego N; Taraktin M; Ryabov M; Gontero P; Compérat E; Shariat SF;
Eur Urol Oncol; 2023 Oct; ():. PubMed ID: 37865570
[No Abstract] [Full Text] [Related]
7. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9.
Soria F; D'Andrea D; Gontero P; Shariat SF
Eur Urol Focus; 2022 Mar; 8(2):633-634. PubMed ID: 33875390
[No Abstract] [Full Text] [Related]
8. Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.
Vila-Reyes H; Joel DeCastro G; McKiernan JM
Eur Urol; 2021 Feb; 79(2):e54-e55. PubMed ID: 33248798
[No Abstract] [Full Text] [Related]
9. Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508-15.
D'Andrea D; Soria F; Hurle R; Enikeev D; Kotov S; Régnier S; Xylinas E; Lusuardi L; Heidenreich A; Cai C; Frego N; Taraktin M; Ryabov M; Gontero P; Compérat E; Shariat SF;
Eur Urol Oncol; 2024 Jun; 7(3):639-640. PubMed ID: 37978025
[No Abstract] [Full Text] [Related]
10. Reply to Eugenio Ventimiglia, Steeve Doizi, Andrea Salonia, and Olivier Traxer's Letter to the Editor re: Farha Pirani, Salima S. Makhani, Frances Y. Kim, et al. Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.02.009.
Pirani F; Makhani S; Kim F; Lay A; Cimmino C; Hartsell L; Spence A; Master VA; Ogan K
Eur Urol Focus; 2021 May; 7(3):666-667. PubMed ID: 32536594
[No Abstract] [Full Text] [Related]
11. Reply to Marco Moschini, Francesco Montorsi, Giuseppe Rosiello, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Stamatios Katsimperis, Lazaros Tzelves, Zafer Tandogdu, et al. Complications After Radical Cystectomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials with a Meta-regression Analysis. Eur Urol Focus 2023;9:920-9.
Katsimperis S; Tzelves L; Tandogdu Z; Ta A; Geraghty R; Bellos T; Manolitsis I; Pyrgidis N; Schulz GB; Sridhar A; Shaw G; Kelly J; Skolarikos A
Eur Urol Focus; 2024 May; ():. PubMed ID: 38749880
[No Abstract] [Full Text] [Related]
12. Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010.
Lombardo R; Riolo S; De Nunzio C
Eur Urol Oncol; 2023 Oct; ():. PubMed ID: 37872030
[No Abstract] [Full Text] [Related]
13. Re: Kristian D. Stensland, Harras Zaid, Mark Broadwin, et al. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2018.11.003.
Moschini M; Zamboni S; Mattei A
Eur Urol Oncol; 2019 Mar; 2(2):230. PubMed ID: 31017104
[No Abstract] [Full Text] [Related]
14. Reply to Nikolaos Grivas, Sanchia Goonewardene, Wouter Everaerts, Nikolaos Kalampokis's Letter to the Editor re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2, Project). Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.07.004.
Mari A; Tellini R; Ficarra V; Carini M; Minervini A;
Eur Urol Focus; 2021 Sep; 7(5):1212-1213. PubMed ID: 33384273
[No Abstract] [Full Text] [Related]
15. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer.
Vetterlein MW; Gild P; Fisch M; Rink M
Eur Urol; 2020 Aug; 78(2):e77-e78. PubMed ID: 32376138
[No Abstract] [Full Text] [Related]
16. Re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.07.010.
Montorsi F; Rosiello G; Gandaglia G; Salonia A; Briganti A
Eur Urol Oncol; 2024 Jun; 7(3):636. PubMed ID: 37951819
[No Abstract] [Full Text] [Related]
17. Re: Antonio Andrea Grosso, Agostino Tuccio, Matteo Salvi, Daniele Paganelli, Andrea Minervini, and Fabrizio Di Maida's Letter to the Editor re: Paolo Capogrosso, Eugenio Ventimiglia, Giuseppe Fallara, et al. Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve. Eur Urol Focus 2023;9:813-21. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.05.013.
Lin YH; Chen ST; Juang HH
Eur Urol Focus; 2024 Jan; ():. PubMed ID: 38272718
[No Abstract] [Full Text] [Related]
18. Re: Ost P, Siva S, Brabrand S, et al. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007.
Montorsi F; Gandaglia G; Barletta F; Briganti A
Eur Urol Oncol; 2024 Feb; ():. PubMed ID: 38418265
[No Abstract] [Full Text] [Related]
19. Reply to Manuela Tutolo, Alberto Briganti, and Francesco Montorsi's Letter to the Editor re: Kathrin Meisterhofer, Sereina Herzog, Karin A. Strini, Luca Sebastianelli, Ricarda Bauer, Orietta Dalpiaz. Male Slings for Postprostatectomy Incontinence: A Systematic Review and Meta-analysis. Eur Urol Focus 2020;6:575-92.
Dalpiaz O; Meisterhofer K
Eur Urol Focus; 2021 Sep; 7(5):1207. PubMed ID: 34755635
[No Abstract] [Full Text] [Related]
20. Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
Stavrinides V; Giganti F; Emberton M; Moore CM
Eur Urol; 2020 Oct; 78(4):e166. PubMed ID: 32712048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
